{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:09:04Z","timestamp":1788307744384,"version":"build-2803163510"},"reference-count":110,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.det.2010.08.014","type":"journal-article","created":{"date-parts":[[2010,11,22]],"date-time":"2010-11-22T09:15:37Z","timestamp":1290417337000},"page":"89-102","source":"Crossref","is-referenced-by-count":24,"title":["Innate Immunity and Leishmania Vaccination Strategies"],"prefix":"10.1016","volume":"29","author":[{"given":"Ron","family":"Birnbaum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Craft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.det.2010.08.014_bib1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4103\/0974-777X.62881","article-title":"Leishmaniasis vaccine: where are we today?","volume":"2","author":"Kedzierski","year":"2010","journal-title":"J\u00a0Glob Infect Dis"},{"issue":"5","key":"10.1016\/j.det.2010.08.014_bib2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4161\/hv.5.5.7607","article-title":"Vaccines and vaccination strategies against human cutaneous leishmaniasis","volume":"5","author":"Okwor","year":"2009","journal-title":"Hum Vaccin"},{"issue":"14","key":"10.1016\/j.det.2010.08.014_bib3","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.vaccine.2008.01.023","article-title":"Vaccines for leishmaniasis in the fore coming 25 years","volume":"26","author":"Palatnik-de-Sousa","year":"2008","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.det.2010.08.014_bib4","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1473-3099(07)70209-8","article-title":"Cutaneous leishmaniasis","volume":"7","author":"Reithinger","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.det.2010.08.014_bib5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1196\/annals.1307.041","article-title":"The immunology of Leishmania infection and the implications for vaccine development","volume":"1026","author":"Vanloubbeeck","year":"2004","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.det.2010.08.014_bib6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12026-008-8016-2","article-title":"Persistent parasites and immunologic memory in cutaneous leishmaniasis: implications for vaccine designs and vaccination strategies","volume":"41","author":"Okwor","year":"2008","journal-title":"Immunol Res"},{"issue":"7","key":"10.1016\/j.det.2010.08.014_bib7","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1590\/S0100-879X2005000700001","article-title":"What about Th1\/Th2 in cutaneous leishmaniasis vaccine discovery?","volume":"38","author":"Campos-Neto","year":"2005","journal-title":"Braz J Med Biol Res"},{"issue":"9496","key":"10.1016\/j.det.2010.08.014_bib8","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances in leishmaniasis","volume":"366","author":"Murray","year":"2005","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.det.2010.08.014_bib9","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1529-8019.2009.01272.x","article-title":"Cutaneous and mucocutaneous leishmaniasis","volume":"22","author":"David","year":"2009","journal-title":"Dermatol Ther"},{"issue":"2","key":"10.1016\/j.det.2010.08.014_bib10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jaad.2009.06.088","article-title":"New World cutaneous leishmaniasis: updated review of current and future diagnosis and treatment","volume":"63","author":"Mitropoulos","year":"2010","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2010.08.014_bib11","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4103\/0974-777X.68528","article-title":"Human immunodeficiency virus and leishmaniasis","volume":"2","author":"Ezra","year":"2010","journal-title":"J\u00a0Global Infect Dis"},{"key":"10.1016\/j.det.2010.08.014_bib12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1600-065X.2006.00432.x","article-title":"Immune privilege in sites of chronic infection: Leishmania and regulatory T\u00a0cells","volume":"213","author":"Peters","year":"2006","journal-title":"Immunol Rev"},{"issue":"11","key":"10.1016\/j.det.2010.08.014_bib13","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nri933","article-title":"The immunology of susceptibility and resistance to Leishmania major in mice","volume":"2","author":"Sacks","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"6915","key":"10.1016\/j.det.2010.08.014_bib14","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nature01152","article-title":"CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity","volume":"420","author":"Belkaid","year":"2002","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.det.2010.08.014_bib15","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.pt.2004.08.009","article-title":"Macrophages, pathology and parasite persistence in experimental visceral leishmaniasis","volume":"20","author":"Engwerda","year":"2004","journal-title":"Trends Parasitol"},{"issue":"3","key":"10.1016\/j.det.2010.08.014_bib16","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2567.2009.03173.x","article-title":"Toll-like receptors\u2013sentries in the B-cell response","volume":"128","author":"Bekeredjian-Ding","year":"2009","journal-title":"Immunology"},{"issue":"15","key":"10.1016\/j.det.2010.08.014_bib17","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.micinf.2004.10.004","article-title":"Dendritic cells in Leishmania infection","volume":"6","author":"Brandonisio","year":"2004","journal-title":"Microbes Infect"},{"issue":"4","key":"10.1016\/j.det.2010.08.014_bib18","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20061141","article-title":"Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis","volume":"204","author":"Nylen","year":"2007","journal-title":"J\u00a0Exp Med"},{"issue":"4","key":"10.1016\/j.det.2010.08.014_bib19","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ijpara.2003.11.021","article-title":"The murine model of infection with Leishmania major and its importance for the deciphering of mechanisms underlying differences in Th cell differentiation in mice from different genetic backgrounds","volume":"34","author":"Gumy","year":"2004","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.det.2010.08.014_bib20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.iy.13.040195.001055","article-title":"The regulation of immunity to Leishmania major","volume":"13","author":"Reiner","year":"1995","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"10.1016\/j.det.2010.08.014_bib21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.micpath.2004.11.002","article-title":"Immunopathogenesis of infection with the visceralizing Leishmania species","volume":"38","author":"Wilson","year":"2005","journal-title":"Microb Pathog"},{"issue":"2-3","key":"10.1016\/j.det.2010.08.014_bib22","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1385\/IR:27:2-3:489","article-title":"Development and regulation of cell-mediated immunity in experimental leishmaniasis","volume":"27","author":"Scott","year":"2003","journal-title":"Immunol Res"},{"issue":"1","key":"10.1016\/j.det.2010.08.014_bib23","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1128\/IAI.74.1.777-780.2006","article-title":"Immunization with persistent attenuated Delta lpg2 Leishmania major parasites requires adjuvant to provide protective immunity in C57BL\/6 mice","volume":"74","author":"Kebaier","year":"2006","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.det.2010.08.014_bib24","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.4049\/jimmunol.176.9.5519","article-title":"Reduced nitric oxide synthase 2 (NOS2) promoter activity in the Syrian hamster renders the animal functionally deficient in NOS2 activity and unable to control an intracellular pathogen","volume":"176","author":"Perez","year":"2006","journal-title":"J\u00a0Immunol"},{"issue":"10","key":"10.1016\/j.det.2010.08.014_bib25","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/nm1108","article-title":"Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites","volume":"10","author":"Zaph","year":"2004","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.det.2010.08.014_bib26","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/j.1462-5822.2005.00626.x","article-title":"Immunologic memory in cutaneous leishmaniasis","volume":"7","author":"Scott","year":"2005","journal-title":"Cell Microbiol"},{"issue":"8","key":"10.1016\/j.det.2010.08.014_bib27","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/90609","article-title":"Toll-like receptors: critical proteins linking innate and acquired immunity","volume":"2","author":"Akira","year":"2001","journal-title":"Nat Immunol"},{"issue":"12","key":"10.1016\/j.det.2010.08.014_bib28","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1007\/s00018-003-3180-y","article-title":"The art of war: Innate and adaptive immune responses","volume":"60","author":"Dempsey","year":"2003","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"10.1016\/j.det.2010.08.014_bib29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/35100529","article-title":"Toll-like receptors and innate immunity","volume":"1","author":"Medzhitov","year":"2001","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.det.2010.08.014_bib30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1034\/j.1600-065X.2000.917309.x","article-title":"Innate immune recognition: mechanisms and pathways","volume":"173","author":"Medzhitov","year":"2000","journal-title":"Immunol Rev"},{"issue":"5","key":"10.1016\/j.det.2010.08.014_bib31","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nri1086","article-title":"NODs: intracellular proteins involved in inflammation and apoptosis","volume":"3","author":"Inohara","year":"2003","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.det.2010.08.014_bib32","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1365-3024.2009.01093.x","article-title":"The scavenger receptor MARCO is involved in Leishmania major infection by CBA\/J macrophages","volume":"31","author":"Gomes","year":"2009","journal-title":"Parasite Immunol"},{"issue":"3","key":"10.1016\/j.det.2010.08.014_bib33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00001432-200306000-00003","article-title":"Toll-like receptors and T-helper-1\/T-helper-2 responses","volume":"16","author":"Dabbagh","year":"2003","journal-title":"Curr Opin Infect Dis"},{"issue":"5663","key":"10.1016\/j.det.2010.08.014_bib34","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1126\/science.1093620","article-title":"Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8","volume":"303","author":"Heil","year":"2004","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.det.2010.08.014_bib35","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ni758","article-title":"Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway","volume":"3","author":"Hemmi","year":"2002","journal-title":"Nat Immunol"},{"issue":"10","key":"10.1016\/j.det.2010.08.014_bib36","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1002\/eji.200324128","article-title":"MyD88 is essential for clearance of Leishmania major: possible role for lipophosphoglycan and Toll-like receptor 2 signaling","volume":"33","author":"de Veer","year":"2003","journal-title":"Eur J Immunol"},{"issue":"4","key":"10.1016\/j.det.2010.08.014_bib37","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0952-7915(03)00070-0","article-title":"Toll-like receptors and innate antiviral responses","volume":"15","author":"Vaidya","year":"2003","journal-title":"Curr Opin Immunol"},{"issue":"2","key":"10.1016\/j.det.2010.08.014_bib38","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.imlet.2006.12.007","article-title":"CpG DNA inhibits CD4+CD25+ Treg suppression through direct MyD88-dependent costimulation of effector CD4+ T cells","volume":"108","author":"LaRosa","year":"2007","journal-title":"Immunol Lett"},{"issue":"8","key":"10.1016\/j.det.2010.08.014_bib39","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.4049\/jimmunol.170.8.4237","article-title":"Genetically resistant mice lacking MyD88-adapter protein display a high susceptibility to Leishmania major infection associated with a polarized Th2 response","volume":"170","author":"Muraille","year":"2003","journal-title":"J\u00a0Immunol"},{"issue":"7","key":"10.1016\/j.det.2010.08.014_bib40","first-page":"942","article-title":"Progress towards a Leishmania vaccine","volume":"27","author":"Tabbara","year":"2006","journal-title":"Saudi Med J"},{"issue":"8","key":"10.1016\/j.det.2010.08.014_bib41","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1128\/IAI.73.8.4714-4722.2005","article-title":"Conditions influencing the efficacy of vaccination with live organisms against Leishmania major infection","volume":"73","author":"Tabbara","year":"2005","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.det.2010.08.014_bib42","first-page":"423","article-title":"Leishmaniasis vaccine candidates for development: a global overview","volume":"123","author":"Khamesipour","year":"2006","journal-title":"Indian J Med Res"},{"issue":"35","key":"10.1016\/j.det.2010.08.014_bib43","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.1016\/j.vaccine.2009.05.084","article-title":"Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis: a meta-analysis","volume":"27","author":"Noazin","year":"2009","journal-title":"Vaccine"},{"issue":"5566","key":"10.1016\/j.det.2010.08.014_bib44","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1071059","article-title":"The danger model: a renewed sense of self","volume":"296","author":"Matzinger","year":"2002","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.det.2010.08.014_bib45","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0301-0546(08)72542-4","article-title":"A\u00a0new era for innate immunity","volume":"36","author":"Montero Vega","year":"2008","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"27\u201328","key":"10.1016\/j.det.2010.08.014_bib46","doi-asserted-by":"crossref","first-page":"5645","DOI":"10.1016\/j.vaccine.2006.03.023","article-title":"Efficacy of vaccination with a combination of Leishmania amastigote antigens and the lipid a-analogue ONO-4007 for immunoprophylaxis and immunotherapy against Leishmania amazonensis infection in a murine model of new world cutaneous leishmaniasis","volume":"24","author":"Calvopina","year":"2006","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.det.2010.08.014_bib47","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.1128\/IAI.73.8.5286-5289.2005","article-title":"Heterologous prime-boost vaccination with the LACK antigen protects against murine visceral leishmaniasis","volume":"73","author":"Dondji","year":"2005","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.det.2010.08.014_bib48","first-page":"439","article-title":"Animal models for vaccine studies for visceral leishmaniasis","volume":"123","author":"Garg","year":"2006","journal-title":"Indian J Med Res"},{"issue":"Suppl","key":"10.1016\/j.det.2010.08.014_bib49","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1017\/S0031182006001831","article-title":"Leishmania vaccines: progress and problems","volume":"133","author":"Kedzierski","year":"2006","journal-title":"Parasitology"},{"issue":"13","key":"10.1016\/j.det.2010.08.014_bib50","first-page":"3528","article-title":"Inhibition of murine tumor growth by an interferon-inducing imidazoquinolinamine","volume":"52","author":"Sidky","year":"1992","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.det.2010.08.014_bib51","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1128\/AAC.33.9.1511","article-title":"Effects of the immunomodulating agent R837 on acute and latent herpes simplex virus type 2 infections","volume":"33","author":"Bernstein","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.det.2010.08.014_bib52","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.4049\/jimmunol.174.3.1259","article-title":"Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8","volume":"174","author":"Gorden","year":"2005","journal-title":"J\u00a0Immunol"},{"issue":"3","key":"10.1016\/j.det.2010.08.014_bib53","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/jlb.58.3.365","article-title":"Cytokine induction by the immunomodulators imiquimod and S-27609","volume":"58","author":"Testerman","year":"1995","journal-title":"J\u00a0Leukoc Biol"},{"issue":"6","key":"10.1016\/j.det.2010.08.014_bib54","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1089\/jir.1995.15.537","article-title":"Cellular requirements for cytokine production in response to the immunomodulators imiquimod and S-27609","volume":"15","author":"Gibson","year":"1995","journal-title":"J\u00a0Interferon Cytokine Res"},{"issue":"4","key":"10.1016\/j.det.2010.08.014_bib55","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1128\/MCB.15.4.2207","article-title":"Stimulation of interferon and cytokine gene expression by imiquimod and stimulation by Sendai virus utilize similar signal transduction pathways","volume":"15","author":"Megyeri","year":"1995","journal-title":"Mol Cell Biol"},{"issue":"11","key":"10.1016\/j.det.2010.08.014_bib56","doi-asserted-by":"crossref","first-page":"6275","DOI":"10.4049\/jimmunol.171.11.6275","article-title":"Injection of immature dendritic cells into adjuvant-treated skin obviates the need for ex vivo maturation","volume":"171","author":"Nair","year":"2003","journal-title":"J\u00a0Immunol"},{"issue":"3","key":"10.1016\/j.det.2010.08.014_bib57","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.4049\/jimmunol.171.3.1156","article-title":"The immune response modifier and Toll-like receptor 7 agonist S-27609 selectively induces IL-12 and TNF-alpha production in CD11c+CD11b+CD8- dendritic cells","volume":"171","author":"Doxsee","year":"2003","journal-title":"J Immunol"},{"issue":"13-14","key":"10.1016\/j.det.2010.08.014_bib58","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.vaccine.2004.01.037","article-title":"Resiquimod is a modest adjuvant for HIV-1 gag-based genetic immunization in a mouse model","volume":"22","author":"Otero","year":"2004","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.det.2010.08.014_bib59","first-page":"189","article-title":"The phenotypic characterization of naturally occurring regulatory CD4+CD25+ T cells","volume":"3","author":"Yi","year":"2006","journal-title":"Cell Mol Immunol"},{"issue":"11","key":"10.1016\/j.det.2010.08.014_bib60","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1086\/324161","article-title":"Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator","volume":"33","author":"Arevalo","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.det.2010.08.014_bib61","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1086\/314782","article-title":"Treatment of experimental leishmaniasis with the immunomodulators imiquimod and S-28463: Efficacy and mode of action","volume":"179","author":"Buates","year":"1999","journal-title":"J\u00a0Infect Dis"},{"issue":"8","key":"10.1016\/j.det.2010.08.014_bib62","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1128\/IAI.01527-07","article-title":"Immunization with a Toll-like receptor 7 and\/or 8 agonist vaccine adjuvant increases protective immunity against Leishmania major in BALB\/c mice","volume":"76","author":"Zhang","year":"2008","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.det.2010.08.014_bib63","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1002\/eji.200636472","article-title":"Immunomodulatory effects associated with a live vaccine against Leishmania major containing CpG oligodeoxynucleotides","volume":"36","author":"Wu","year":"2006","journal-title":"Eur J Immunol"},{"issue":"8","key":"10.1016\/j.det.2010.08.014_bib64","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1128\/IAI.73.8.4948-4954.2005","article-title":"Prevention and treatment of cutaneous leishmaniasis in primates by using synthetic type D\/A oligodeoxynucleotides expressing CpG motifs","volume":"73","author":"Flynn","year":"2005","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.det.2010.08.014_bib65","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pt.2005.03.006","article-title":"Second-generation vaccines against leishmaniasis","volume":"21","author":"Coler","year":"2005","journal-title":"Trends Parasitol"},{"issue":"7","key":"10.1016\/j.det.2010.08.014_bib66","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.4049\/jimmunol.180.7.4825","article-title":"Leishmania major-specific B cells are necessary for Th2 cell development and susceptibility to L. major LV39 in BALB\/c mice","volume":"180","author":"Ronet","year":"2008","journal-title":"J\u00a0Immunol"},{"issue":"5","key":"10.1016\/j.det.2010.08.014_bib67","doi-asserted-by":"crossref","first-page":"854","DOI":"10.4269\/ajtmh.2007.77.854","article-title":"Cellular analysis of cutaneous leishmaniasis lymphadenopathy: insights into the early phases of human disease","volume":"77","author":"Bomfim","year":"2007","journal-title":"Am J Trop Med Hyg"},{"issue":"5891","key":"10.1016\/j.det.2010.08.014_bib68","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1126\/science.1159194","article-title":"In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies","volume":"321","author":"Peters","year":"2008","journal-title":"Science"},{"issue":"16","key":"10.1016\/j.det.2010.08.014_bib69","doi-asserted-by":"crossref","first-page":"6748","DOI":"10.1073\/pnas.0900226106","article-title":"Leishmania amazonensis promastigotes induce and are killed by neutrophil extracellular traps","volume":"106","author":"Guimaraes-Costa","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.det.2010.08.014_bib70","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/j.1462-5822.2009.01348.x","article-title":"The impact of vector-mediated neutrophil recruitment on cutaneous leishmaniasis","volume":"11","author":"Peters","year":"2009","journal-title":"Cell Microbiol"},{"issue":"2","key":"10.1016\/j.det.2010.08.014_bib71","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1189\/jlb.0706440","article-title":"Leishmania major induces distinct neutrophil phenotypes in mice that are resistant or susceptible to infection","volume":"82","author":"Charmoy","year":"2007","journal-title":"J\u00a0Leukoc Biol"},{"issue":"12","key":"10.1016\/j.det.2010.08.014_bib72","doi-asserted-by":"crossref","first-page":"8088","DOI":"10.4049\/jimmunol.0803720","article-title":"Neutrophils and macrophages cooperate in host resistance against Leishmania braziliensis infection","volume":"183","author":"Novais","year":"2009","journal-title":"J\u00a0Immunol"},{"issue":"6","key":"10.1016\/j.det.2010.08.014_bib73","doi-asserted-by":"crossref","first-page":"e1000484","DOI":"10.1371\/journal.ppat.1000484","article-title":"Vector transmission of Leishmania abrogates vaccine-induced protective immunity","volume":"5","author":"Peters","year":"2009","journal-title":"PLoS Pathog"},{"issue":"2","key":"10.1016\/j.det.2010.08.014_bib74","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/eji.200535079","article-title":"RNA interference reveals a role for TLR2 and TLR3 in the recognition of Leishmania donovani promastigotes by interferon-gamma-primed macrophages","volume":"36","author":"Flandin","year":"2006","journal-title":"Eur J Immunol"},{"issue":"90","key":"10.1016\/j.det.2010.08.014_bib75","doi-asserted-by":"crossref","first-page":"ra58","DOI":"10.1126\/scisignal.2000213","article-title":"Leishmania GP63 alters host signaling through cleavage-activated protein tyrosine phosphatases","volume":"2","author":"Gomez","year":"2009","journal-title":"Sci Signal"},{"issue":"4","key":"10.1016\/j.det.2010.08.014_bib76","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.4049\/jimmunol.174.4.2205","article-title":"IL-9 is a susceptibility factor in Leishmania major infection by promoting detrimental Th2\/type 2 responses","volume":"174","author":"Arendse","year":"2005","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"10.1016\/j.det.2010.08.014_bib77","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12026-007-8012-y","article-title":"l-Arginine metabolism and its impact on host immunity against Leishmania infection","volume":"41","author":"Wanasen","year":"2008","journal-title":"Immunol Res"},{"issue":"6","key":"10.1016\/j.det.2010.08.014_bib78","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1213\/ANE.0b013e3181bea01d","article-title":"Pressure waveform monitoring during central venous catheterization","volume":"109","author":"Bowdle","year":"2009","journal-title":"Anesth Analg"},{"issue":"7","key":"10.1016\/j.det.2010.08.014_bib79","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.4049\/jimmunol.180.7.4355","article-title":"Modulation of dendritic cell function by Leishmania parasites","volume":"180","author":"Soong","year":"2008","journal-title":"J\u00a0Immunol"},{"issue":"3-4","key":"10.1016\/j.det.2010.08.014_bib80","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.imbio.2007.12.005","article-title":"The innate immune response against Leishmania parasites","volume":"213","author":"Liese","year":"2008","journal-title":"Immunobiology"},{"issue":"11","key":"10.1016\/j.det.2010.08.014_bib81","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1128\/CVI.00249-09","article-title":"Vaccination with live Leishmania major and CpG DNA promotes interleukin-2 production by dermal dendritic cells and NK cell activation","volume":"16","author":"Laabs","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"7","key":"10.1016\/j.det.2010.08.014_bib82","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1128\/IAI.00154-09","article-title":"Distinct roles for MyD88 and Toll-like receptor 2 during Leishmania braziliensis infection in mice","volume":"77","author":"Vargas-Inchaustegui","year":"2009","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.det.2010.08.014_bib83","doi-asserted-by":"crossref","first-page":"e1000222","DOI":"10.1371\/journal.ppat.1000222","article-title":"Migratory dermal dendritic cells act as rapid sensors of protozoan parasites","volume":"4","author":"Ng","year":"2008","journal-title":"PLoS Pathog"},{"issue":"8","key":"10.1016\/j.det.2010.08.014_bib84","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1128\/IAI.01447-08","article-title":"Leishmania major phosphoglycans influence the host early immune response by modulating dendritic cell functions","volume":"77","author":"Liu","year":"2009","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.det.2010.08.014_bib85","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.4049\/jimmunol.172.10.6281","article-title":"Dendritic cells (DC) activated by CpG DNA ex vivo are potent inducers of host resistance to an intracellular pathogen that is independent of IL-12 derived from the immunizing DC","volume":"172","author":"Ramirez-Pineda","year":"2004","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.det.2010.08.014_bib86","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.4049\/jimmunol.180.7.4371","article-title":"Dendritic cell differentiation state and their interaction with NKT cells determine Th1\/Th2 differentiation in the murine model of Leishmania major infection","volume":"180","author":"Wiethe","year":"2008","journal-title":"J\u00a0Immunol"},{"issue":"6","key":"10.1016\/j.det.2010.08.014_bib87","doi-asserted-by":"crossref","first-page":"e1000494","DOI":"10.1371\/journal.ppat.1000494","article-title":"iNOS-producing inflammatory dendritic cells constitute the major infected cell type during the chronic Leishmania major infection phase of C57BL\/6 resistant mice","volume":"5","author":"De Trez","year":"2009","journal-title":"PLoS Pathog"},{"issue":"2","key":"10.1016\/j.det.2010.08.014_bib88","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0166-6851(03)00160-9","article-title":"Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2","volume":"130","author":"Becker","year":"2003","journal-title":"Mol Biochem Parasitol"},{"issue":"3","key":"10.1016\/j.det.2010.08.014_bib89","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1365-2249.2003.02096.x","article-title":"Live Leishmania promastigotes can directly activate primary human natural killer cells to produce interferon-gamma","volume":"131","author":"Nylen","year":"2003","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.det.2010.08.014_bib90","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.0300-9475.2004.01388.x","article-title":"Leishmanial amastigote antigen P-2 induces major histocompatibility complex class II-dependent natural killer-cell reactivity in cells from healthy donors","volume":"59","author":"Nylen","year":"2004","journal-title":"Scand J Immunol"},{"issue":"3","key":"10.1016\/j.det.2010.08.014_bib91","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.vaccine.2009.10.053","article-title":"Innate immune defense in visceral leishmaniasis: cytokine mediated protective role by allogeneic effector cell","volume":"28","author":"Manna","year":"2010","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.det.2010.08.014_bib92","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1096\/fj.06-5860com","article-title":"Skin mast cells control T cell-dependent host defense in Leishmania major infections","volume":"20","author":"Maurer","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.det.2010.08.014_bib93","article-title":"Mast cells are activated by Leishmania mexicana LPG and regulate the disease outcome depending on the genetic background of the host","author":"Villasenor-Cardoso","year":"2008","journal-title":"Parasite Immunol"},{"issue":"3","key":"10.1016\/j.det.2010.08.014_bib94","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1365-3024.2008.01084.x","article-title":"Mast cell degranulation contributes to susceptibility to Leishmania major","volume":"31","author":"Romao","year":"2009","journal-title":"Parasite Immunol"},{"issue":"6","key":"10.1016\/j.det.2010.08.014_bib95","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/eji.200939821","article-title":"The MyD88 protein 88 pathway is differently involved in immune responses induced by distinct substrains of Leishmania major","volume":"40","author":"Revaz-Breton","year":"2010","journal-title":"Eur J Immunol"},{"issue":"6","key":"10.1016\/j.det.2010.08.014_bib96","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.4049\/jimmunol.172.6.3793","article-title":"Vaccination with phosphoglycan-deficient Leishmania major protects highly susceptible mice from virulent challenge without inducing a strong Th1 response","volume":"172","author":"Uzonna","year":"2004","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.det.2010.08.014_bib97","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.exppara.2009.09.017","article-title":"Leishmania major lipophosphoglycan: discrepancy in Toll-like receptor signaling","volume":"124","author":"Kavoosi","year":"2010","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.det.2010.08.014_bib98","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2613.2010.00717.x","article-title":"Histopathological analysis of initial cellular response in TLR-2 deficient mice experimentally infected by Leishmania (L) amazonensis","author":"Guerra","year":"2010","journal-title":"Int J Exp Pathol"},{"issue":"10","key":"10.1016\/j.det.2010.08.014_bib99","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1017\/S0031182009990473","article-title":"The involvement of TLR2 in cytokine and reactive oxygen species (ROS) production by PBMCs in response to Leishmania major phosphoglycans (PGs)","volume":"136","author":"Kavoosi","year":"2009","journal-title":"Parasitology"},{"issue":"4","key":"10.1016\/j.det.2010.08.014_bib100","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1128\/IAI.72.4.1920-1928.2004","article-title":"Toll-like receptor 4 contributes to efficient control of infection with the protozoan parasite Leishmania major","volume":"72","author":"Kropf","year":"2004","journal-title":"Infect Immun"},{"issue":"1\u20132","key":"10.1016\/j.det.2010.08.014_bib101","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijmm.2007.07.011","article-title":"CpG oligonucleotides as adjuvant in therapeutic vaccines against parasitic infections","volume":"298","author":"Zimmermann","year":"2008","journal-title":"Int J Med Microbiol"},{"issue":"8","key":"10.1016\/j.det.2010.08.014_bib102","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1096\/fj.04-3416fje","article-title":"Arginase and polyamine synthesis are key factors in the regulation of experimental leishmaniasis in vivo","volume":"19","author":"Kropf","year":"2005","journal-title":"FASEB J"},{"issue":"8","key":"10.1016\/j.det.2010.08.014_bib103","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1128\/IAI.01335-06","article-title":"Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice","volume":"75","author":"Rocha","year":"2007","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.det.2010.08.014_bib104","doi-asserted-by":"crossref","first-page":"e743","DOI":"10.1371\/journal.pntd.0000743","article-title":"Kinetic analysis of ex vivo human blood infection by Leishmania","volume":"4","author":"Moreno","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"10.1016\/j.det.2010.08.014_bib105","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.4049\/jimmunol.172.8.4902","article-title":"A\u00a0leucine-rich repeat motif of Leishmania parasite surface antigen 2 binds to macrophages through the complement receptor 3","volume":"172","author":"Kedzierski","year":"2004","journal-title":"J\u00a0Immunol"},{"issue":"10","key":"10.1016\/j.det.2010.08.014_bib106","doi-asserted-by":"crossref","first-page":"6724","DOI":"10.4049\/jimmunol.0902374","article-title":"Complement activation by CpG in a human whole blood loop system: mechanisms and immunomodulatory effects","volume":"183","author":"Mangsbo","year":"2009","journal-title":"J\u00a0Immunol"},{"issue":"3","key":"10.1016\/j.det.2010.08.014_bib107","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.exppara.2010.02.006","article-title":"Interactions of antimicrobial peptides with Leishmania and trypanosomes and their functional role in host parasitism","volume":"126","author":"McGwire","year":"2010","journal-title":"Exp Parasitol"},{"issue":"12","key":"10.1016\/j.det.2010.08.014_bib108","doi-asserted-by":"crossref","first-page":"8346","DOI":"10.4049\/jimmunol.175.12.8346","article-title":"Saliva from Lutzomyia longipalpis induces CC chemokine ligand 2\/monocyte chemoattractant protein-1 expression and macrophage recruitment","volume":"175","author":"Teixeira","year":"2005","journal-title":"J\u00a0Immunol"},{"issue":"22","key":"10.1016\/j.det.2010.08.014_bib109","doi-asserted-by":"crossref","first-page":"7845","DOI":"10.1073\/pnas.0712153105","article-title":"Immunity to a salivary protein of a sand fly vector protects against the fatal outcome of visceral leishmaniasis in a hamster model","volume":"105","author":"Gomes","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.det.2010.08.014_bib110","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1371\/journal.pntd.0000226","article-title":"Immunity to distinct sand fly salivary proteins primes the anti-Leishmania immune response towards protection or exacerbation of disease","volume":"2","author":"Oliveira","year":"2008","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863510001397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863510001397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T12:48:55Z","timestamp":1559825335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863510001397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":110,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0733863510001397"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2010.08.014","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}